Transition Therapeutics Inc.
415 Yonge Street
Suite 1103
Toronto
Ontario
M5B2E7
Canada
Tel: 416-260-7770
Fax: 416-260-2886
183 articles about Transition Therapeutics Inc.
-
Transition Therapeutics's Alzheimer's Drug Effective in ELND005 Phase II/III Study
10/15/2015
-
Transition Therapeutics Inc. Announces Fiscal 2015 Financial Results
9/16/2015
-
Transition Therapeutics Inc. To Hold Conference Call On Fiscal 2015 Financial Results On Tuesday, September 15th, At 4:30 P.M. EST
9/14/2015
-
Transition Therapeutics Inc. To Present At The Canaccord Genuity 35th Annual Growth Conference
8/11/2015
-
Transition Therapeutics Inc. Announces Results Of Clinical Study Of ELND005 In Agitation And Aggression In Patients With Alzheimer's Disease
6/24/2015
-
Transition Therapeutics Inc. Appoints Carl Damiani As President
6/16/2015
-
Transition Therapeutics Inc. To Present At The Jefferies and Co. 2015 Healthcare Conference
5/26/2015
-
Transition Therapeutics Inc. Announces Third Quarter Fiscal 2015 Financial Results
5/13/2015
-
Transition Therapeutics Inc. In-Licenses Phase 2 Drug Candidate From Eli Lilly
5/11/2015
-
Transition Therapeutics Inc. To Hold Conference Call On Third Quarter Fiscal 2015 Financial Results On Tuesday, May 12th, At 4:30 P.M. EST
5/8/2015
-
Transition Therapeutics Inc. Announces Results From Phase 1 AME & Renal Clearance Clinical Studies Of Neuropsychiatric Drug Candidate ELND005
3/26/2015
-
Transition Therapeutics Inc. Announces Enrolment Completion Of ELND005 Phase 2 Clinical Study In Agitation And Aggression In Patients With Alzheimer's Disease
3/2/2015
-
Transition Therapeutics Inc. To Present At The Cowen and Company 35th Annual Healthcare Conference
2/19/2015
-
Transition Therapeutics Inc. Announces Closing Of Public Offering Of US$23 Million Of Common Shares
2/18/2015
-
Transition Therapeutics Inc. Announces Pricing Of Public Offering Of US$20 Million Of Common Shares
2/12/2015
-
Transition Therapeutics Inc. Announces Public Offering Of Common Shares
2/11/2015
-
Transition Therapeutics Inc. Announces Second Quarter Fiscal 2015 Financial Results
2/10/2015
-
Transition Therapeutics Inc. To Hold Conference Call On Second Quarter Fiscal 2015 Financial Results On Monday, February 9th, At 4:30 P.M. EST
2/5/2015
-
Transition Therapeutics Inc. To Present At The Oppenheimer 25th Annual Healthcare Conference
12/9/2014
-
Transition Therapeutics Inc.' ELND005 Showed No Prolongation Of QT Interval
11/24/2014